[HTML][HTML] Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential …
JC Jakobsen, KK Katakam, A Schou, SG Hellmuth… - BMC psychiatry, 2017 - Springer
Background The evidence on selective serotonin reuptake inhibitors (SSRIs) for major
depressive disorder is unclear. Methods Our objective was to conduct a systematic review …
depressive disorder is unclear. Methods Our objective was to conduct a systematic review …
Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential …
JC Jakobsen, KK Katakam, A Schou… - BMC …, 2017 - pubmed.ncbi.nlm.nih.gov
Background The evidence on selective serotonin reuptake inhibitors (SSRIs) for major
depressive disorder is unclear. Methods Our objective was to conduct a systematic review …
depressive disorder is unclear. Methods Our objective was to conduct a systematic review …
Erratum to: Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial …
JC Jakobsen, KK Katakam, A Schou, SG Hellmuth… - BMC Psychiatry, 2017 - Springer
1. Results section, under Hamilton depression rating scale (HDRS): In the sentence
'Nineteen trials reported only mean HDRS change scores or presented a graph showing the …
'Nineteen trials reported only mean HDRS change scores or presented a graph showing the …
Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential …
JC Jakobsen, KK Katakam, A Schou, SG Hellmuth… - BMC …, 2017 - go.gale.com
Methods Our objective was to conduct a systematic review assessing the effects of SSRIs
versus placebo,'active'placebo, or no intervention in adult participants with major depressive …
versus placebo,'active'placebo, or no intervention in adult participants with major depressive …
[引用][C] Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential …
JC Jakobsen, KK Katakam, A Schou, SG Hellmuth… - BMC Psychiatry, 2017 - cir.nii.ac.jp
Selective serotonin reuptake inhibitors versus placebo in patients with major depressive
disorder. A systematic review with meta-analysis and Trial Sequential Analysis | CiNii Research …
disorder. A systematic review with meta-analysis and Trial Sequential Analysis | CiNii Research …
Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential …
JC Jakobsen, KK Katakam, A Schou, SG Hellmuth… - BMC Psychiatry, 2017 - infona.pl
Background The evidence on selective serotonin reuptake inhibitors (SSRIs) for major
depressive disorder is unclear. Methods Our objective was to conduct a systematic review …
depressive disorder is unclear. Methods Our objective was to conduct a systematic review …
[PDF][PDF] Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential …
JC Jakobsen, KK Katakam, A Schou, SG Hellmuth… - 2017 - d-nb.info
Background: The evidence on selective serotonin reuptake inhibitors (SSRIs) for major
depressive disorder is unclear. Methods: Our objective was to conduct a systematic review …
depressive disorder is unclear. Methods: Our objective was to conduct a systematic review …
Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential …
JC Jakobsen, KK Katakam, A Schou, SG Hellmuth… - BMC …, 2017 - europepmc.org
Methods Our objective was to conduct a systematic review assessing the effects of SSRIs
versus placebo,'active'placebo, or no intervention in adult participants with major depressive …
versus placebo,'active'placebo, or no intervention in adult participants with major depressive …
Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential …
JC Jakobsen, KK Katakam, A Schou… - BMC …, 2017 - search.ebscohost.com
Background: The evidence on selective serotonin reuptake inhibitors (SSRIs) for major
depressive disorder is unclear. Methods: Our objective was to conduct a systematic review …
depressive disorder is unclear. Methods: Our objective was to conduct a systematic review …
Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential …
JC Jakobsen, KK Katakam, A Schou, SG Hellmuth… - BMC psychiatry, 2017 - safetylit.org
BACKGROUND: The evidence on selective serotonin reuptake inhibitors (SSRIs) for major
depressive disorder is unclear. METHODS: Our objective was to conduct a systematic …
depressive disorder is unclear. METHODS: Our objective was to conduct a systematic …